Pharma IQ Members

Active Pharmaceutical Ingredient

Active Pharmaceutical Ingredient (API) is any substance or mixture of substances intended to be used in the manufacture of a drug (medicinal) product and that, when used in the production of a drug, becomes an active ingredient of the drug product. Such substances are intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure and function of the body.

Pharma IQ Surveys
 Create your free online surveys with SurveyMonkey, the world's leading questionnaire tool. in conjunction with Pharmaceutical Serialisation and Traceability Summit 2012 would like to invite you to take part in a short survey, which...
Contributor: Pharma IQ Surveys
07/22/2012 08:00:00 PM EDT
Andrea Charles

Choosing the right platform or conference to showcase your product and services to potential clients in the pharma space can be a challenge for those working in business development, sales and marketing. In this podcast Martin Peter, Head of...

Contributor: Andrea Charles
06/17/2012 08:00:00 PM EDT
Pharma IQ News

In a chilling new book Roger Bate blows the whistle on what could be America’s greatest health crisis.

“Phake: The Deadly World of Falsified and Substandard Medicines” reveals how ruthless criminals penetrate the pharmaceutical market...

Contributor: Pharma IQ News
06/14/2012 08:00:00 PM EDT
IN PROFILE: 2011 Top 10 Players in the Japanese Pharmaceutical Market

Pharma IQ provides you with a quick update of the activities of the Top 10 players in the Japanese pharmaceutical market in 2011. Figures according to Forbes The World Biggest Companies.1. Takeda Pharmaceutical Sales of $15.7 billionCEO Yasuchika...

Contributor: Pharma IQ
06/29/2011 08:00:00 PM EDT
Andrea Charles

The DIA Global Award winners were announced this morning at the opening plenary session of DIA 2011.  Recognised for a range of achievements the winners were:

Distinguished Career Award – EuropeMartin Terberger Retired, European Commission ...

Contributor: Andrea Charles
06/19/2011 08:00:00 PM EDT
Helen Winsor

Marc Descamps, Professor in Solid State Physics at Université Lille and Lead of the European ID Network for Improved Drug Efficacy and Availability, joins Helen Winsor from Pharma IQ, to discuss the use of amorphous pharmaceutical materials to...

Contributor: Helen Winsor
05/31/2011 08:00:00 PM EDT
Jeffrey Gren

Jeffrey Gren, Director of the Office of Health and Consumer Goods, joins Pharma IQ to address some solutions to the increase in the volume and the level of sophistication of counterfeiting as part of the impact of the globalisation of the...

Contributor: Jeffrey Gren
05/26/2011 08:00:00 PM EDT
Cost Savings Still the Number One Reason Behind 60% of Outsourced Pharma and Bio Manufacturing

While there is normally more than one factor behind the decision of a pharmaceutical or biopharmaceutical organisation to outsource its global manufacturing, it seems the ever-important cost-saving potential remains among the main attraction of...

Contributor: Pharma IQ
05/16/2011 08:00:00 PM EDT
Helen Winsor

Mark Gibson, Consumer Information Specialist at Gibson Research Consultancy, joins Helen Winsor form Pharma IQ, to discuss packaging and labelling in the healthcare industry. In this exclusive interview, Gibson outlines the main considerations in...

Contributor: Helen Winsor
05/08/2011 08:00:00 PM EDT
Cristina Falcão

Based on new regulations, increased costs of R & D, the expiration of dozens of patents, the lack of future ‘cash cows’, the new transparency rules and the value-based pricing, pharmaceutical companies need to brace themselves for very tough...

Contributor: Cristina Falcão
03/23/2011 08:00:00 PM EDT
Are Pharmaceutical Supply Chains Due an Outsourcing Overhaul?

The current manufacturing and distribution infrastructure of drugmakers across the globe may be uanble to cope with the future challenges facing pharmaceuticals worldwide. Research published by PricewaterhouseCoopers (PwC) in February warned that...

Contributor: Pharma IQ
03/09/2011 07:00:00 PM EST
Pharma IQ News

Demand planning in turbulent market conditions is challenging, doing it while other people are throwing different figures at you is even worse, and getting the forecast 100% correct is impossible – so how can we ensure our figures are as close to...

Contributor: Pharma IQ News
03/07/2011 07:00:00 PM EST
Aparna Krishnan

The Middle East and the North Africa (MENA) region constitutes just 2 per cent of global pharmaceutical sales. A rapid increase in population has stoked drug demand especially for higher-yield pharmaceutical products attracting the attention of...

Contributor: Aparna Krishnan
09/12/2010 08:00:00 PM EDT
Pharma IQ

Daniel Schick, Executive Director, Commercial Affairs & Key Account Management for Janssen-Cilag, spoke to Andrea Charles from Pharma IQ, about the current challenges facing pharmaceutical sales force effectiveness. In this podcast, he shares...

Contributor: Pharma IQ
08/03/2010 08:00:00 PM EDT
Pharma IQ

In this Pharma IQ podcast, Isabel Henkel, Director, Access & Reimbursement at Johnson & Johnson Medical, talks about how the pharma industry needs to adjust to the new requirements of the German government’s pharmaceutical savings...

Contributor: Pharma IQ
07/28/2010 08:00:00 PM EDT